Bernhard Scheiner

8.4k citations
210 papers · 6.0k · 3 hit papers · h-index 40

Impact in

  • Hepatology top 0.2%
    • Liver Disease and Transplantation
    • Hepatocellular Carcinoma Treatment and Prognosis
    • Hepatitis C virus research
    • Liver Disease Diagnosis and Treatment
    • Hepatitis B Virus Studies

Papers in

    • Liver Disease and Transplantation 70
    • Hepatocellular Carcinoma Treatment and Prognosis 55
    • Hepatitis C virus research 22
    • Liver Disease Diagnosis and Treatment 44
    • Hepatitis B Virus Studies 6

Bernhard Scheiner

195 papers receiving 6.0k citations

Bernhard Scheiner's Hit Papers

Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: A real‐world study 2022 · 186 citations
1860+1+3Years since publication2505007501000

Peers

Bernhard Scheiner
Comparison fields: 5 of 103
  • Hepatology 3.5k
  • Epidemiology 2.0k
  • Oncology 852
  • Cancer Research 320
  • Pathology and Forensic Medicine 334
Replace Francesco Giuseppe Foschi with:
Francesco Giuseppe Foschi Italy
Massimo Alberto Iavarone Italy
Joon Hyeok Lee South Korea
Albert Chi Yan Chan Hong Kong
Giuseppe Cabibbo Italy
Tianfu Wen China
Yung Sang Lee South Korea
Annette S.H. Gouw Netherlands
Yoshinari Asaoka Japan
Masanori Atsukawa Japan
Bernhard Scheiner relative to Francesco Giuseppe Foschi Italy Francesco Giuseppe Foschi's profile →
Citations per field
00.5×2×3×4.1×
Francesco Giuseppe Foschi · 1×
Citations per year

Countries citing papers authored by Bernhard Scheiner

Since Specialization
Citations

This map shows the geographic impact of Bernhard Scheiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard Scheiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard Scheiner more than expected).

Fields of papers citing papers by Bernhard Scheiner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernhard Scheiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard Scheiner. The network helps show where Bernhard Scheiner may publish in the future.

Co-authors

The 25 scholars most cited alongside Bernhard Scheiner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bernhard Scheiner Line = papers co-authored together Bernhard Scheiner links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 210 papers — load more, or switch the sort, to bring in the rest.

#Work
1
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
Hit paper breakdown →
20211006
2
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
Hit paper breakdown →
2021226
3 2020187
4
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: A real‐world study
Hit paper breakdown →
2022186
5 2020186
6 2020155
7 2018138
8 2019111
9 2021102
10 202396
11 202288
12 202287
13 202380
14 201679
15 201778
16 202374
17 202172
18 202069
19 202363
20 201963

About Bernhard Scheiner

Bernhard Scheiner is a scholar working on Hepatology, Epidemiology, Oncology, Immunology and Pathology and Forensic Medicine, having authored 210 papers that have together received 6.0k indexed citations. Recurring topics across this work include Liver Disease and Transplantation (70 papers), Hepatocellular Carcinoma Treatment and Prognosis (55 papers), Liver Disease Diagnosis and Treatment (44 papers), Hepatitis C virus research (22 papers), Cancer Immunotherapy and Biomarkers (19 papers), Colorectal Cancer Treatments and Studies (9 papers), Organ Transplantation Techniques and Outcomes (6 papers) and Hepatitis B Virus Studies (6 papers). The work is most often cited by research in Hepatology (3.5k citations), Epidemiology (2.0k citations), Oncology (852 citations), Cancer Research (320 citations) and Pathology and Forensic Medicine (334 citations). Bernhard Scheiner has collaborated with scholars based in Austria, Germany and United Kingdom. Frequent co-authors include Matthias Pinter, Thomas Reiberger, Michael Trauner, Mattias Mandorfer, Markus Peck‐Radosavljevic, Philipp Schwabl, Benedikt Simbrunner, David Josef Maria Bauer, Rafael Paternostro and Georg Semmler. Their work appears in journals such as Journal of Hepatology, Liver International, JHEP Reports, Alimentary Pharmacology & Therapeutics and Cancers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact